期刊文献+

TLR9与TLR4在非小细胞肺癌组织中的表达及临床意义

Expression of TLR9 and TLR4 in non-small cell lung cancer tissue and its clinical significance
原文传递
导出
摘要 目的探讨TLR9和TLR4在非小细胞肺癌组织中的表达情况,并与正常组织进行对比,总结其临床意义。方法选取2010年3月至2012年8月间收治行手术切除的49例非小细胞肺癌患者,应用免疫组化方法检测TLR9和TLR4在30例癌旁正常组织和49例非小细胞肺癌组织中的表达情况。探讨非小细胞肺癌在临床分期、病理分级及淋巴结转移与TLR9和TLR4之间的相互关系。结果非小细胞肺癌组织中TLR9阳性率为93.9%(46/49),TLR4阳性率为59.2%(29/49)。正常肺组织中TLR9阳性率为16.7%(5/30),TLR4阳性率为10.0%(3/30)。非小细胞肺癌组织中TLR9和TLR4的阳性率明显高于正常肺组织,差异有统计学意义(P<0.05)。TLR4的表达与非小细胞肺癌的肿瘤分级关系密切(P<0.05)。结论在非小细胞肺癌组织中TLR9和TLR4呈高表达状态,且肿瘤分级与TLR4的表达关系密切,在非小细胞肺癌的发生、发展过程中二者可能有所参与,为非小细胞肺癌的治疗提供新的思路。 Objective To study TLR9 and TLR4 expression in non-small cell lung cancer, and compare with normal group, summarize its clinical significance. Methods 49 patients with non-small cell lung cancer from March 2010 to August 2012 in our hospital were included in the study. The immunohisto- chemical method was used to detect TLR9 and TLR4 in 30 cases with normal tissue of adjacent carcinoma and 49 cases of non-small cell lung cancer tissue. Explored non-small cell lung cancer in clinical stage, pathological grading and lymph node metastasis and the relationship with TLR4 and TLR9. Results 46 ca- ses of TLR9 in non-small cell lung cancer tissues were positive ( 93.9% ) ; TLR4 in 29 cases for positive (59.2%). TLR9 had 5 cases in normal lung tissue was positive( 16. 7% ) ; TLR4 in 3 cases for positive ( 10. 0% ). TLR9 in non-small cell lung cancer tissues and the positive rate of TLR4 was obviously higher than that of normal lung tissue ( P 〈 0. 05 ). The expression of TLR4 and small cell lung cancer was closely related to tumor grade ( P 〈 0. 05 ). Conclusions TLR9 and TLR4 in non-small cell lung cancer tissue has high status, and closely related to tumor grade and the expression of TLR4 in non-small cell lung cancer oc- currence and development process of the two might be involved, providing a new method for the treatment of non-small cell lung cancer.
出处 《中国肿瘤临床与康复》 2013年第9期935-937,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 非小细胞肺 TLR9 TLR4 临床意义 Carcinom non-small cell lung TLR9 TLR4 Clinical significance
  • 相关文献

参考文献12

二级参考文献139

  • 1王孟昭,张晓彤,张新勇,张力,钟巍,徐丽艳,李龙芸.厄罗替尼单药治疗晚期非小细胞肺癌的疗效和安全性分析[J].中国医学科学院学报,2010,32(2):151-156. 被引量:7
  • 2叶宏勋,刘阳晨,高飞,周邵兵,赵莺.立体定向适形放疗配合常规放疗治疗非小细胞肺癌的近期疗效观察[J].临床肿瘤学杂志,2004,9(6):655-656. 被引量:5
  • 3何凤莲,张志红,王道兵,张红,张妍蓓.TLR4与TLR9在非小细胞肺癌组织中的表达及临床意义[J].肿瘤,2006,26(12):1098-1101. 被引量:10
  • 4Krieg AM. Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov, 2006, 5:471-484.
  • 5Krieg AM. CpG motifs in bacterial DNA and their immune effects. Ann Rev Immunol, 2002, 20:709-760.
  • 6Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature, 2000, 408:740-745.
  • 7Gekeler V, Gimnmich P, Hofmann HP, et al. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxy nucleotides are potent suppressors of the growth of human tumor xenografts in nude mice. Oligonucleotides, 2006, 16:83-93.
  • 8Kunikata N, Sano K, Honda M, et aL Peritumoral CpG oligodeoxynucleotlde treatment inhibits tumor growth and metastasis of B16F10 melanoma cells. J Invest Dermatol, 2004, 123: 395 -402.
  • 9Lonsdorf AS, Kuekrek H, Stem BV, et al. Intratumor CpGoligodeoxy nucleotide injection induces protective antitumor T cell immunity. J Immunol, 2003, 171:3941-3946.
  • 10Brown L, Roda J, Terrell C, et aL Interferon alpha and CPG oligodeoxynucleotides elicit additive immunostimulatory and antitumor effects. Surgery. 2006. 140:297-306.

共引文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部